Terms of Use
The short version: this is a free reference tool, not legal advice, and nothing here is for sale.
The site
PAMAwatch is a free research tool: a checker and a method page about PAMA private-payor-rate reporting for independent clinical laboratories. Nothing on this site is for sale, there is no account to create, and no payment is ever requested. It is provided as is, with no warranty of accuracy or availability.
Not legal or financial advice
This site is independent research, not legal or financial advice, and using it creates no advisor-client relationship of any kind. It reads a lab's own public CMS Medicare billing data against PAMA's published low expenditure threshold and reports a comparison; it does not review your lab's actual revenue mix, does not account for facts outside that public data, and makes no promise about your lab's real PAMA reporting status. Decisions about your lab's reporting obligations should be made with whoever handles your Medicare billing, not from this site alone.
The underlying data
The checker's data comes from CMS's own public Medicare billing and CLIA datasets, self-reported and republished on CMS's own schedule. Each result page shows the billing year it was built from. A stale or incomplete figure on CMS's side will produce a stale or incomplete result here; this site has no way to correct or verify what CMS has published.
Acceptable use
Use the site for its intended purpose: looking up a lab's own public billing comparison. No attempts to scrape, overload, or probe the site beyond normal use, and no automated bulk querying.
Liability
To the extent the law allows, PAMAwatch and the people who built it are not liable for any decision made in reliance on this site, including any cost, penalty, or compliance failure that follows from it. Nothing here limits liability the law does not allow limiting.
Changes
Content on this site, including the underlying dataset and the method page, may be updated at any time without notice as CMS's own published data or guidance changes.